Cargando…
MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis()()
Breast cancer is a heterogeneous disease comprising the estrogen receptor (ER)–positive luminal subtype which is subdivided into luminal A and luminal B and ER-negative breast cancer which includes the triple-negative subtype. This study has four aims: 1) to examine whether Minichromosome Maintenanc...
Autores principales: | Issac, Marianne Samir Makboul, Yousef, Einas, Tahir, Muhammad Ramzan, Gaboury, Louis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726925/ https://www.ncbi.nlm.nih.gov/pubmed/31476594 http://dx.doi.org/10.1016/j.neo.2019.07.011 |
Ejemplares similares
-
MCM-GINS and MCM-MCM interactions in vivo visualised by bimolecular fluorescence complementation in fission yeast
por: Akman, Gökhan, et al.
Publicado: (2009) -
Molecular functions of MCM8 and MCM9 and their associated pathologies
por: Helderman, Noah Cornelis, et al.
Publicado: (2023) -
Interactions of the Human MCM-BP Protein with MCM Complex Components and Dbf4
por: Nguyen, Tin, et al.
Publicado: (2012) -
O-GlcNAc transferase associates with the MCM2–7 complex and its silencing destabilizes MCM–MCM interactions
por: Leturcq, Maïté, et al.
Publicado: (2018) -
The Saccharomyces cerevisiae Mcm6/2 and Mcm5/3 ATPase active sites contribute to the function of the putative Mcm2-7 ‘gate’
por: Bochman, Matthew L., et al.
Publicado: (2010)